{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "exchange": "STO", "shortName": "PILA PHARMA AB", "longName": "Pila Pharma AB (publ)", "messageBoardId": "finmb_329992468", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "esgPopulated": false, "regularMarketChangePercent": 1.3605429, "regularMarketPrice": 2.98, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1626332400000, "priceHint": 4, "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 18407400, "bookValue": 0.518, "fiftyDayAverage": 2.6569, "fiftyDayAverageChange": 0.3231001, "fiftyDayAverageChangePercent": 0.12160793, "twoHundredDayAverage": 3.3464766, "twoHundredDayAverageChange": -0.36647654, "twoHundredDayAverageChangePercent": -0.10951116, "marketCap": 54854052, "priceToBook": 5.752896, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.03999996, "regularMarketTime": 1684143032, "regularMarketDayHigh": 3.05, "regularMarketDayRange": "2.98 - 3.05", "regularMarketDayLow": 2.98, "regularMarketVolume": 3000, "regularMarketPreviousClose": 2.94, "bid": 2.41, "ask": 2.98, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 3.05, "averageDailyVolume3Month": 10464, "averageDailyVolume10Day": 4525, "fiftyTwoWeekLowChange": 1.064, "fiftyTwoWeekLowChangePercent": 0.5553236, "fiftyTwoWeekRange": "1.916 - 6.0", "fiftyTwoWeekHighChange": -3.02, "fiftyTwoWeekHighChangePercent": -0.50333333, "fiftyTwoWeekLow": 1.916, "fiftyTwoWeekHigh": 6.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "PILA.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Norra Vallgatan 72", "city": "Malm\u00f6", "zip": "211 22", "country": "Sweden", "phone": "46 7 39 03 69 69", "website": "https://pilapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malm\u00f6, Sweden.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Ms. Dorte Xenia Gram", "age": 53, "title": "Founder, CEO & Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 1630309, "fmt": "1.63M", "longFmt": "1,630,309"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elna Lembrer Astrom", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2021, "totalPay": {"raw": 246821, "fmt": "246.82k", "longFmt": "246,821"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Miguel  Lecumberri", "title": "Head of Compliance & Legal Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gustav Hanghoj Gram", "title": "Head of Office", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Masoud  Alavi", "title": "Head of Corp. Visual Communication", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andy  Makin", "title": "Head of Toxicology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Maura  McArdle", "title": "Head of BD & Quay Pharma", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mike  Frodsham", "title": "CTO of Quay Pharma", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Alison  Foster", "title": "Head of Pre-Clinical - Quay Pharma", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon  Hamilton", "title": "Head of Global Bus. Devel. - Almac", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}